The addition of chemotherapy to radiotherapy was not associated with improved survival among patients with intermediate-risk ...

Patients were of a median age of 51 years old – 78% with SCC and 22% with adenocarcinoma or adenosquamous carcinoma – and randomised to receive 350mg Libtayo every three weeks or chemotherapy ...

It is probably a squamous cell carcinoma. Please see a dermatologist and have it biopsied.' Dr Brown also urged the public to take preventative steps to avoid the disease. ‘You can prevent ...

The ampulla is part of the digestive system. It is also called the ampulla of Vater. It is where bile and pancreatic juices drain into the first part of the small bowel. Doctors call this part of the ...

The approvals were based on results from a phase 2 trial and a phase 3 trial. The US Food and Drug Administration (FDA) has approved the PD-1 inhibitor penpulimab-kcqx for 2 indications ...

A retrospective analysis comparing cabozantinib (Cabometyx) plus nivolumab (Opdivo; C+N) with lenvatinib (Lenvima) plus pembrolizumab (Keytruda; L+P) as frontline treatment for advanced renal cell ...

Lung cancer is one of the deadliest forms of cancer, and for many patients, asbestos exposure may be to blame. You may be eligible for compensation if you've been diagnosed with lung cancer caused by ...

(UroToday.com) The 2025 AUA annual meeting featured an upper tract urothelial carcinoma session and a presentation by Dr. Jiwei Huang discussing results of a phase II study of tislelizumab as ...

Special Projects in Key Areas for Guangdong Provincial Collegens and Universities ...